¾È³çÇϼ¼¿ä.´Ù¼Ø¸ÞµðÄÉ¾î °ü¸®ÀÚÀÔ´Ï´Ù.
°Ç°º¸Çè½É»çÆò°¡¿ø ȨÆäÀÌÁö °øÁö»çÇ׿¡
[¾àÁ¦] °í½Ã Á¦2025-169È£ ¿ä¾ç±Þ¿©ÀÇ Àû¿ë±âÁØ ¹× ¹æ¹ý¿¡ °üÇÑ ¼¼ºÎ»çÇ× ¾È³»°¡ ÀÖ¾î °Ô½ÃÇÕ´Ï´Ù.
°ü·Ã¾÷¹«¿¡ Âü°íÇϽñ⠹ٶø´Ï´Ù.
º¸°Çº¹ÁöºÎ °í½Ã Á¦2025-169È£
¡¸±¹¹Î°Ç°º¸Çè¹ý¡¹ Á¦41Á¶Á¦3Ç× ¹× Á¦4Ç×, ¡¸±¹¹Î°Ç°º¸Çè ¿ä¾ç±Þ¿© ±âÁØ¿¡ °üÇÑ ±ÔÄ¢¡¹Á¦5Á¶Á¦2Ç׿¡ µû¶ó¡¸¿ä¾ç±Þ¿©ÀÇ Àû¿ë±âÁØ ¹× ¹æ¹ý¿¡ °üÇÑ ¼¼ºÎ»çÇס¹(º¸°Çº¹ÁöºÎ °í½Ã Á¦2025-143È£(2025. 8. 26.)À» ´ÙÀ½°ú °°ÀÌ °³Á¤¤ý¹ß·ÉÇÕ´Ï´Ù.
2025³â 9¿ù 26ÀÏ
º¸°Çº¹ÁöºÎÀå°ü
¡¸¿ä¾ç±Þ¿©ÀÇ Àû¿ë±âÁØ ¹× ¹æ¹ý¿¡ °üÇÑ ¼¼ºÎ»çÇס¹ÀϺΰ³Á¤
¿ä¾ç±Þ¿©ÀÇ Àû¿ë±âÁØ ¹× ¹æ¹ý¿¡ ´ëÇÑ ¼¼ºÎ»çÇ× ÀϺθ¦ ´ÙÀ½°ú °°ÀÌ °³Á¤ÇÑ´Ù.
¥±. ¾àÁ¦ “[259] Atosiban ÁÖ»çÁ¦(ǰ¸í : Æ®·¢Åä½ÇÁÖ µî), [319] Odevixibat °æ±¸Á¦ (ǰ¸í: ºôº£ÀÌĸ½¶ 200¸¶ÀÌÅ©·Î±×·¥ µî)”À» º°Áö 1°ú °°ÀÌ ½Å¼³Çϰí, “[ÀϹݿøÄ¢] °í°¡ÀǾàǰ ±Þ¿©°ü¸®¿¡ °üÇÑ ±âÁØ, [ÀϹݿøÄ¢] ´ç´¢º´¿ëÁ¦, [142] Cyclosporine °æ±¸Á¦(ǰ¸í:»çÀÌÆú¿£¿¬Áúݼ¿ µî), [142] CyclosporineÁÖ»çÁ¦(ǰ¸í : »êµð¹®ÁÖ µî), [142] Mycophenolate mofetil °æ±¸Á¦(ǰ¸í: ¼¿¼ÁƮĸ½¶ µî), [142] Tacrolimus Á¦Á¦(ǰ¸í: ÇÁ·Î±×¶øÄ°¼¿·ÁÖ»ç µî), [396] Empagliflozin °æ±¸Á¦(ǰ¸í: ÀÚµð¾ÓÁ¤ 10¹Ð¸®±×·¥), [421] Methotrexate Á¦Á¦, [421] RituximabÁÖ»çÁ¦(ǰ¸í: ¸¿Å×¶óÁÖ µî), [634] Antithrombin III, human ÁÖ»çÁ¦(ǰ¸í:¾ÈƼƮ·ÒºóIII ÁÖ µî), [634] Human Immunoglobulin G ÁÖ»çÁ¦(ǰ¸í: ¾ÆÀ̺ñ±Û·ÎºÒ¸°¿¡½º¾ØÁÖ µî), [639] Eculizumab ÁÖ»çÁ¦(ǰ¸í: ¼Ö¸®¸®½ºÁÖ µî), [639] Ravulizumab ÁÖ»çÁ¦(ǰ¸í: ¿ïÅä¹Ì¸®½ºÁÖ µî), [721] PEG3350¿Ü(ǰ¸í: ÄÚ¸®Æ®»ê µî)”ÀÇ ±¸ºÐ, ¼¼ºÎÀÎÁ¤±âÁØ ¹× ¹æ¹ýÀÇ ÀϺθ¦ º°Áö 2¿Í °°ÀÌ º¯°æÇÑ´Ù.
ºÎ Ä¢
ÀÌ °í½Ã´Â 2025³â 10¿ù 1ÀϺÎÅÍ ½ÃÇàÇÑ´Ù. ´Ü, [396] Empagliflozin °æ±¸Á¦(ǰ¸í: ÀÚµð¾ÓÁ¤ 10¹Ð¸®±×·¥), [ÀϹݿøÄ¢] ´ç´¢º´¿ëÁ¦´Â 2025³â 10¿ù 24ÀϺÎÅÍ ½ÃÇàÇÑ´Ù.
< °Ç°º¸Çè½É»çÆò°¡¿ø >
¡Û ½Å¼³
- [259] Atosiban ÁÖ»çÁ¦(ǰ¸í: Æ®·¢Åä½ÇÁÖ µî): ¢Ï 033-739-1355
- [319] Odevixibat °æ±¸Á¦ (ǰ¸í: ºôº£ÀÌĸ½¶ 200¸¶ÀÌÅ©·Î±×·¥ µî): ¢Ï 033-739-1365
¡Û º¯°æ
- [ÀϹݿøÄ¢] ´ç´¢º´¿ëÁ¦: ¢Ï 033-739-1355
- [142] Cyclosporine °æ±¸Á¦(ǰ¸í: »çÀÌÆú¿£¿¬Áúݼ¿ µî): ¢Ï 033-739-1354
- [142] Cyclosporine ÁÖ»çÁ¦(ǰ¸í: »êµð¹®ÁÖ µî): ¢Ï 033-739-1354
- [142] Mycophenolate mofetil °æ±¸Á¦ (ǰ¸í: ¼¿¼ÁƮĸ½¶ µî): ¢Ï 033-739-1354
- [142] Tacrolimus Á¦Á¦(ǰ¸í: ÇÁ·Î±×¶øÄ°¼¿·ÁÖ»ç µî): ¢Ï 033-739-1354
- [396] Empagliflozin °æ±¸Á¦ (ǰ¸í: ÀÚµð¾ÓÁ¤ 10¹Ð¸®±×·¥ µî): ¢Ï 033-739-1355
- [421] Methotrexate Á¦Á¦: ¢Ï 033-739-1354
- [421] Rituximab ÁÖ»çÁ¦ (ǰ¸í: ¸¿Å×¶óÁÖ µî): ¢Ï 033-739-1344(½ÅÁõÈıº), 1354(´Ù¹ß¼º±Ù¿° ¶Ç´Â ÇǺαٿ°)
- [634] Antithrombin III, human ÁÖ»çÁ¦(ǰ¸í:¾ÈƼƮ·ÒºóIII ÁÖ µî): ¢Ï 033-739-1330
- [634] Human Immunoglobulin G ÁÖ»çÁ¦ (ǰ¸í: ¾ÆÀ̺ñ±Û·ÎºÒ¸°¿¡½º¾ØÁÖ µî): ¢Ï 033-739-1354(´Ù¹ß¼º±Ù¿° ¶Ç´Â ÇǺαٿ°), 1339(ÁßÁõ±Ù¹«·ÂÁõ)
- [639] Eculizumab ÁÖ»çÁ¦(ǰ¸í: ¼Ö¸®¸®½ºÁÖ µî)): ¢Ï 033-739-1349
- [639] Ravulizumab ÁÖ»çÁ¦(ǰ¸í: ¿ïÅä¹Ì¸®½ºÁÖ µî): ¢Ï 033-739-1349
- [721] PEG3350 ¿Ü (ǰ¸í: ÄÚ¸®Æ®»ê µî): ¢Ï 033-739-1355